This work elucidates that HDAC2 knockdown retards the process of ESCC by elevating miR-503-5p and inhibiting CXCL10 expression, which may provide a guidance for ESCC management. The gene discussed is HDAC2; the disease is esophageal squamous cell carcinoma.